Saxenda belongs to a class of medicines called glucagon-like peptide-1 (GLP-1) receptor agonists
Three years and nine months later, Williams in incredible physical condition at 44 and her fearsome ball-striking are back
The report uncovers strong consumer satisfaction with GLP-1s and highlights how these medications reshape retail trends and long-term dietary behaviors
The majority of the reported events occurred in patients who had experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting, or diarrhea
It is possible that for some people, a lower dose may produce fewer side effects, but it will likely be less effective for most people
When administered therapeutically, GLP-1 receptor agonists work through several mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner [1] [4] Suppressing glucagon release from alpha cells, reducing hepatic glucose output Slowing gastric emptying , which helps moderate post-meal blood glucose rises Promoting satiety through central nervous system pathways, potentially supporting weight reduction Investigational transdermal GLP-1 delivery systems typically utilise specialised technologies such as microneedles or active delivery methods rather than conventional patches, as GLP-1 molecules are large peptides that do not easily penetrate the skin barrier
